BIO270 Differences Between Males And Females In Cardiovascular Health

Johns Hopkins Medicine
6 followers
Dec 21, 2024
Gender-specific differences in cardiovascular health are influenced by a combination of
biological, hormonal and behavioral factors. These differences affect the prevalence, presentation,
treatment and outcomes of cardiovascular disease, which is CVD, in men and women.
First, biological differences. Heart size and structure. On average, women have smaller
hearts and thinner coronary arteries than men. This can affect the symptoms, progression
and treatment outcomes of the heart diseases.
The other one, blood pressure regulation. Men are more prone to higher systolic blood
pressure at an earlier age, while women experience a significant rise in blood pressure post-menopause.
About hormonal influence, estrogen in women. Estrogen in women acts as a protective role,
which is, before menopause, estrogen helps maintain the flexibility of blood vessels
and regulates cholesterol, reducing the risk of atherosclerosis, post-menopause risk.
After menopause, estrogen levels drop, leading to increased LDL, which is the bad cholesterol,
and decreased HDL, which is the good cholesterol, raising the risk of cardiovascular diseases.
While testosterone in men may offer some cardiovascular benefits, high levels are associated with
increased risk of hypertension, cholesterol issues and metabolic syndrome.
The third is, differences in disease prevalence. Coronary artery diseases, which is CAD, more
common in men than women, especially before women reach menopause. In women, CAD often
manifests after in life, but can be more severe.
Heart failure. Men are more likely to experience heart failure with reduced ejection fraction,
which is HFREF. Women are more prone to heart failure with preserved ejection fraction,
which is HFPEF, often linked to hypertension and diastolic dysfunction.
While hypertension affects men more commonly before age 65, after menopause, women surpass
men in prevalence.
Arterial fibrillation. Women with arterial fibrillation have higher risk of stroke compared
to men.
I will continue this presentation and explain how risk factors for cardiovascular disease
or CVDs differ between males and females. We categorise these factors into two groups,
non-modifiable and modifiable. So let's start with the non-modifiable factors, which are
those we cannot change.
The first point is age. Males face a higher risk of CVD earlier in life because of the
condition like atherosclerosis. The build-up of blood in the arteries tend to develop sooner.
The second point is about gender. Men are more prone to coronary artery disease, CID,
earlier in life, driven by the influence of gastroenteritis and supermoisture factors.
However, women are more likely to develop heart failure, which means their heart pumps
normally but does not fill properly.
Women also experience atypical symptoms like fatigue or nausea, which can delay diagnosis.
Now let's move to the modifiable factors, which are risk we can change to lifestyle
and behaviour.
So first, lifestyle factors. In females, postmenopausal diets that are low in protective nutrients
like phytoestrogens can worsen cardiovascular risk. In contrast, males tend to consume more
red meats and processed food, which increase cholesterol levels and contribute to heart
disease.
Last but not least is obesity. Obesity impacts both genders but in slightly different ways.
In females, central obesity, weight gain around the abdomen, becomes a significant driver
of CVD risk, especially after menopause. In contrast, for males, the focus is on visceral
fat accumulation which surrounds the internal organ. Visceral fat is a medically active
and worsens cardiovascular risk by increasing inflammation and insulin resistance.
Hi, so today I want to tell you about hormonal influence in cardiovascular health.
So we start with estrogen and progesterone in females. Estrogen provides cardiovascular
protection during reproduction, thereby promoting vasodilation, regulating lipid metabolism,
reducing inflammation and vascular stiffness.
Postmenopause is the decline in estrogen lead to increased risk of hypertension and myocardial
infarction. Progesterone is modulated vasculature and fluid retention, influencing blood pressure
and risk of pregnancy, related complications such as preeclampsia.
So we continue with testosterone in males. At psychological level, it promotes cardio
output and supports muscle mass. At elevated level, it increases atherosclerosis,
leads to biased LDL cholesterol and reduced HDL cholesterol.
Males experience highest rate of ischemic, heart disease, IHD, and younger age compared
to females.
So we continue with lifestyle factors. The first one is caloric intake.
For male, first one is higher caloric intake. Men tend to consume more calories often due
to highest energy need. However, this can also lead to overconsumption of unhealthy
food.
Second one is preference for saturated fat. Males are more likely to consume diet rich
in red meat, processed food and saturated fat, which increase LDL cholesterol level, leading
to highest rates of atherosclerosis and coronary artery disease.
For females, it's better dietary choice. Females typically consume more fruits, vegetables
and whole grains, which are associated with improved cardiovascular health due to their
anti-inflammatory and antioxidant properties.
The last one is emphasis on weight control. Females are more likely to adopt a strict
diet to manage body weight, in which if extreme, it may lead to nutrient deficiencies and impair
heart function.
Next, we move to smoking and alcohol consumption. Smokers are more likely to present with early
onset of CVD, and the disease may be more advanced at diagnosis.
System of CVD is, smoker may include chest pain. Shortness of breath, fatigue and irregular
heartbeat, often manifesting earlier than in non-smoker.
Alcohol consumption, or heavy drinker often present with alcohol-related CVD such as hypertension
or cardiomyopathy, and representation may include severe fatigue, edema or shortness
of breath.
Genetic variations significantly influence the development of cardiovascular disease,
and these risks vary between men and women due to biological and hormonal factors.
For instance, women are more prone to arrhythmias such as Long QT syndrome, which can be attributed
to hormonal influences and genetic variations in ion channel function.
Men, on the other hand, have a higher risk of coronary artery disease, often tied to
genetic influences affecting lipid metabolism and blood formation in arteries.
Furthermore, gene-environment interactions such as the interplay between genetic predispositions
and lifestyle factors like smoking, diet and physical activity can amplify these risks
in a gender-specific manner.
For example, men with genetic tendencies toward higher cholesterol may see greater risk of
poor diet, while women with ion channel mutations may be more affected by hormonal changes during
pregnancy or menopause.
These interactions underline the complexity of CVD risk factors across genders.
Variations in cardiovascular outcomes between males and females result from a complex interplay
of hormonal, lifestyle and genetic factors.
Hormones play a key role with estrogen providing cardiovascular protection in pre-menopausal
women by improving vascular health and regulating lipid profiles.
However, after menopause, the loss of estrogen leads to increased risk of arterial calluses
and hypertension.
In men, testosterone-laid implants lipid profiles by raising LDL and lowering HDL cholesterol
levels, contributing to a higher risk of coronary artery disease.
Lifestyle factors also contribute to these differences.
Men's higher consumption of red meat and lower adherence to balanced diets contribute to
effluent cholesterol levels, while women's healthier eating habits offer some protection
although disadvantaged in many issues post-menopause.
Additionally, men have historically exhibited higher smoking and alcohol consumption rates
which significantly elevate CVD risk.
On the other hand, women's heightened response to emotional stress increase their self-capability
to stress-induced cardiomyopathy.
Genetics further explains gender-specific outcomes.
Women are more prone to arrhythmia-like long QT symptoms, often leading to ion channel
gene mutation and hormonal change.
Men, however, have a higher prevalence of coronary artery disease, driven by genetic
differences in lipid metabolism and blood formation.
Gene-environment interactions, such as the influence of diet or smoking on genetic predispositions,
exacerbate this risk differently in men and women.
These combined factors result in distinct cardiovascular outcomes.
Therefore, women are more likely to experience microvascular disease, arrhythmias and stress-related
cardiac conditions, while men face higher rates of coronary artery blockage and an earlier
onset of cardiovascular disease.
Understanding these variations is essential for developing tailored prevention and treatment strategies.
To continue the presentation, I will discuss topics that involve both chart and table,
related to an article that records data from 2010 to 2019.
So let's dive into the first topic.
Here we can see the gender difference in cardiovascular disease, or CDV, incidence over age group.
In the chart above, there are two different types of color lines that represent both genders.
For men, the risk starts increasing significantly in their 40s and peaks around their 60s.
But for women, the risk remains relatively lower until the postmenopause, where it accelerates
and eventually surpasses men in older age group.
The second topic is about the gender comparison of survival rates and diagnostic delays.
The table above illustrates two critical disparities in cardiovascular outcomes between genders.
The first one, women experience an average diagnostic delay of 6.7 hours compared to 4.5 hours in men.
This delay is primarily due to atypical symptoms presented in women, such as fatigue, mysteria,
which differ from the classic chest pain typically seen in men.
The second one is survival rates also reflect this disparity.
One year after a heart attack, men have a survival rate of 78%, while women trend at 17%,
partially due to this diagnostic delay and less timely treatment.
In conclusion, cardiovascular health is influenced by a combination of hormonal,
lifestyles and genetic factors that vary between genders.
For example, hormonal differences like estrogen, protective effects in women play a significant role
in reducing cardiovascular risk until menopause.
In the other hand, men may experience risk early due to a difference in hormonal levels
and lifestyle factors such as higher risk of smoking or alcohol use.
Synthetic predispositions also interact uniquely with the gender,
shaping how cardiovascular conditions manifest.
Recognizing this difference early allows for tenuous cleanings and treatment,
which can significantly improve the patient's outcome.
Moreover, advancing research mentioned the specific cardiovascular health is essential
because future studies should explore more of these factors in track to define its presence.
Personalized medical interventions for its default impact prevention strategies
could include addressing lifestyle habits specific to women and men,
designing medications tailored to the unique physiological response to each gender.
These steps are crucial for closing gaps in diagnosis, treatment and prevention.
Ultimately, understanding and addressing gender-specific difference is not just about advising science,
it's about making a meaningful impact on life by embracing these decisions in healthcare.
We can save more lives through these disparities and move forward
to a future where everyone receives care that aligns with their individual needs.
